Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06634966
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-08
Brief Title:
Segmentectomy for Solid-dominant Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Segmentectomy for Solid-dominant GGO-featured Invasive Lung Cancer With Size of 2-3cm a Single-arm Multi-center Phase III Trial
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a clinical trial from Eastern Cooperative Thoracic Oncology Project ECTOP numbered as ECTOP-1025 The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm The main questions it aims to answer are
The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm
The post-operative lung function tests after receiving segmentectomy Participants will receive segmentectomy as the surgical procedure
The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm
The post-operative lung function tests after receiving segmentectomy Participants will receive segmentectomy as the surgical procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None